NCT06615011 (AlBaathU) is a clinical trial in Bardet Biedl Syndrome (BBS), sponsored by Al Baath University.

Who is sponsoring NCT06615011?

NCT06615011 is sponsored by Al Baath University.

What condition does NCT06615011 study?

NCT06615011 studies Bardet Biedl Syndrome (BBS).

Is NCT06615011 still recruiting?

NCT06615011 is currently not yet recruiting. Last updated 27 September 2024.

Last reviewed 2024-09-27 · How we verify

NCT06615011: AlBaathU

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Bardet Beidle Syndrome in a Syrian Adolescent : a Rare Case Report

Not yet recruiting Last updated 27 September 2024

What this trial tests

trial in Bardet Biedl Syndrome (BBS) in 100 participants. Not yet recruiting.

Timeline

12 October 2024

Primary endpoint
12 September 2025

12 October 2025

Quick facts

Lead sponsor	Al Baath University
Status	Not yet recruiting
Study type	OBSERVATIONAL
Enrollment	100
Start date	12 October 2024
Primary completion	12 September 2025
Estimated completion	12 October 2025

Conditions studied

Bardet Biedl Syndrome (BBS) — all drugs for Bardet Biedl Syndrome (BBS) →

Sponsor

Al Baath University

Who can join

Eligibility, any sex, with Bardet Biedl Syndrome (BBS). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Bardet-Biedl Syndrome (BBS) is an uncommon genetic disorder that affects multiple organs. and presents with a variety of characteristics. It is caused by a dysfunction in the cilia. We present a case of bradet-biedl syndrome presenting with intellectual disabilities, post-axial polydactyly, gingival hyperplasia, and a significant family history of scleroderma. The diagnosis was determined based on clinical physical examination findings. The patient is undergoing treatment with Thyroxine. Although medical staff are incapable of treatment, systems support adjust the overall well-being and quality of life for individuals with Bardet-Biedl syndrome and their families.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Bardet-Biedl syndrome in a Syrian adolescent: a rare case report.
Alabed A, Alhallak S, Dakkak T, Alhaj Ali AJ, et al · · 2025 · PMID 40486581 · DOI 10.1097/ms9.0000000000003077

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06615011 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Al Baath University
Last refreshed: 27 September 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06615011.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing